Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Mitrabahtera Segara Sejati Tbk. (MBSS) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Mitrabahtera Segara Sejati Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Mitrabahtera Segara Sejati Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Mitrabahtera Segara Sejati Tbk. trades at Rp2,830 (market cap 4.97T, 531.9K 24h volume). The key difference: Mitrabahtera Segara Sejati Tbk. is far larger — about 15.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Mitrabahtera Segara Sejati Tbk. is more actively traded (531.9K versus 41.7K). Which is the better fit depends on your goals.

DGNSMBSS
Market Cap
316.25B4.97T
Volume
41.7K531.9K
Lot
4175.32K
Turnover
9.66M1.51B
Average Price
231.652,838.25
Value
9.66M1.51B
Indicative Equilibrium Price
2302,830
Indicative Equilibrium Volume
2.4K842

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
MBSS
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Mitrabahtera Segara Sejati Tbk.

PT Mitrabahtera Segara Sejati Tbk (the company) was established on 24 Mar 1994 based on Notaries Deed No. 107 and the deed of establishment was approved by the the Ministry of Justice dated Nov 6, 1996. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Fathiah Helmi, S.H., dated Dec 13, 2010, concerning among others, the change in the Company’s name, and public offering.

Read more on MBSS